BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4990554)

  • 41. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F; Marteau R; de Saxcé H
    Rev Neurol (Paris); 1987; 143(2):98-107. PubMed ID: 3299618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The clinical use of antilymphocyte globulin (ALG) (author's transl)].
    Brendel W; Seifert J; Ring J
    MMW Munch Med Wochenschr; 1975 Aug; 117(35):1361-8. PubMed ID: 809676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The disappearance curve of horse antilymphocyte globulins labeled with I-131 and I-125 in long term treatment of posttransplantation patients].
    Berthoux F; Traeger J; Revillard JP
    Proc Eur Dial Transplant Assoc; 1972; 9():388-9. PubMed ID: 4204157
    [No Abstract]   [Full Text] [Related]  

  • 44. Glomerular damage after intravenous administration of antilymphocyte globulin (ALG) in man and rhesus monkeys.
    Moppert J; Thiel G; Mahlich J; Bühler F; Vischer T; Enderlin F; Weber H; Zollinger HU
    Transplant Proc; 1971 Mar; 3(1):741-4. PubMed ID: 4999468
    [No Abstract]   [Full Text] [Related]  

  • 45. [The antigen-elimination technique in dogs. Evaluation of the method].
    Seifert J; Fateh-Moghadam A; Hopf U; Land W; Brendel W; Lob G
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 156(3):157-70. PubMed ID: 5003684
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical use of rabbit antihuman lymphocyte globulin in cadaver-kidney transplantation.
    Mannick JA; Davis RC; Cooperband SR; Glasgow AH; Williams LF; Harrington JT; Cavallo T; Schmitt GW; Idelson BA; Olsson CA; Nabseth DC
    N Engl J Med; 1971 May; 284(20):1109-15. PubMed ID: 4928659
    [No Abstract]   [Full Text] [Related]  

  • 47. In vivo elimination of equine antilymphocyte globulin by renal allograft recipients.
    Schmidtke JR; Rynasiewicz J; Gifford RR; Ferguson RM; Najarian JS
    Clin Immunol Immunopathol; 1980 Mar; 15(3):409-14. PubMed ID: 6989529
    [No Abstract]   [Full Text] [Related]  

  • 48. [Coupled heart-kidney homotransplantation in the dog abdomen. Conditioning by association of horse antilymphocyte serum, azathioprine and prednisone].
    Legrain M; Dubois M; Rottembourg J; Gandjbakhch I; Wajcner G; Guilmet D
    J Urol Nephrol (Paris); 1969 Sep; 75(9):615-20. PubMed ID: 4933478
    [No Abstract]   [Full Text] [Related]  

  • 49. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract]   [Full Text] [Related]  

  • 50. Human renal allografts. Glomerular deposits of horse immunoglobulin G and nephritis following administration of antilymphocyte globulin.
    Busch GJ; Birtch AG; Lukl P; Kobayashi K; Galvanek EG; Carpenter CB
    Hum Pathol; 1971 Jun; 2(2):299-308. PubMed ID: 4937849
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies with anti-lymphocytic antibody and antibody-fragments.
    James K
    Prog Immunobiol Stand; 1970; 4():256-64. PubMed ID: 4394821
    [No Abstract]   [Full Text] [Related]  

  • 52. Development of rapid plasma clearance of antilymphocytic globulin in renal transplant patients.
    Butler WT; Rossen RD; Morgen RO; Trentin JJ; Judd KP; Knight V
    Fed Proc; 1970; 29(1):194-6. PubMed ID: 4904624
    [No Abstract]   [Full Text] [Related]  

  • 53. Desensitisation to horse-globulin before immunosuppressive treatment.
    Moberg AW; Gewurz H; Simmons RL; Najarian JS
    Lancet; 1970 Jul; 2(7665):214. PubMed ID: 4193598
    [No Abstract]   [Full Text] [Related]  

  • 54. [Induction of immunological tolerance to horse serum IgG in adult dogs].
    Land W; Seifert J; Fateh-Moghadam A; Hopf U; Brendel W
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(2):117-37. PubMed ID: 4982478
    [No Abstract]   [Full Text] [Related]  

  • 55. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG; May J; Rogers JH; Storey BG; Katran DC; Duggin GG; Johnson JR; Stewart JH
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract]   [Full Text] [Related]  

  • 56. Whole antilymphocyte serum: a potent safe immunosuppressive agent for intravenous use in man.
    Levey RH; Parkman R
    Transplant Proc; 1977 Mar; 9(1):1019-22. PubMed ID: 405764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on goat anti-CBA thymocyte globulin: the immunosuppressive activity of anti-lymphocyte globulin in mice tolerant to, or sensitized to, goat gamma-globulin.
    Fahey KJ
    Aust J Exp Biol Med Sci; 1973 Aug; 51(4):501-11. PubMed ID: 4128656
    [No Abstract]   [Full Text] [Related]  

  • 58. [Use of antilymphocyte globulin in the treatment of rheumatoid arthritis].
    Iannotta F; Fantini F; Colombo B
    Minerva Med; 1974 Jan; 65(5):241-8. PubMed ID: 4856472
    [No Abstract]   [Full Text] [Related]  

  • 59. The appearance of reticulum cell sarcoma at the site of antilymphocyte globulin injection.
    Cotton JR; Searls AG; Remmers AR; Lindley JD; Beathard GA; Cottom DL; Fish JC; Townsend CM; Ritzmann SE
    Transplantation; 1973 Aug; 16(2):154-7. PubMed ID: 4581401
    [No Abstract]   [Full Text] [Related]  

  • 60. Prediction of long term combined imuran ALG dosage.
    Ollodart RM; Flotte CT; Lubash GD; Young JD; Sadler JH; Ramos E
    Proc Clin Dial Transplant Forum; 1972; 2():8-16. PubMed ID: 4219814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.